EP 4419087 A1 20240828 - PHARMACEUTICAL COMPOSITION COMPRISING MIRABEGRON IN MATRIX FORM
Title (en)
PHARMACEUTICAL COMPOSITION COMPRISING MIRABEGRON IN MATRIX FORM
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT MIRABEGRON IN MATRIXFORM
Title (fr)
COMPOSITION PHARMACEUTIQUE COMPRENANT DU MIRABÉGRON SOUS FORME DE MATRICE
Publication
Application
Priority
TR 2021051417 W 20211215
Abstract (en)
[origin: WO2023113706A1] The present invention relates to a prolonged release formulation comprising mirabegron or a pharmaceutically acceptable salt thereof with at least two hydrogel forming agents and a binder to obtain improved release profile in three different physiological media of gastrointestinal tract for use in the treatment of overactive bladder.
IPC 8 full level
A61K 9/20 (2006.01); A61K 31/426 (2006.01); A61K 47/10 (2017.01); A61P 13/10 (2006.01)
CPC (source: EP)
A61K 9/2031 (2013.01); A61K 9/2054 (2013.01); A61K 31/426 (2013.01); A61P 13/10 (2018.01)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
DOCDB simple family (application)
TR 2021051417 W 20211215; EP 21968317 A 20211215